Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics granted stock options to purchase an aggregate of 20,800 shares to four new non-executive employees as inducement awards. The options have a 10-year term and an exercise price of $69.42, which equals the closing price on the grant date.
Key figures
- Offering Price
- 69.42
- Shares Offered
- 20800
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.